Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury.

Davies AJ, Kim HW, Gonzalez-Cano R, Choi J, Back SK, Roh SE, Johnson E, Gabriac M, Kim MS, Lee J, Lee JE, Kim YS, Bae YC, Kim SJ, Lee KM, Na HS, Riva P, Latremoliere A, Rinaldi S, Ugolini S, Costigan M, Oh SB.

Cell. 2019 Feb 7;176(4):716-728.e18. doi: 10.1016/j.cell.2018.12.022. Epub 2019 Jan 31.

2.

High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice.

Crinier A, Milpied P, Escalière B, Piperoglou C, Galluso J, Balsamo A, Spinelli L, Cervera-Marzal I, Ebbo M, Girard-Madoux M, Jaeger S, Bollon E, Hamed S, Hardwigsen J, Ugolini S, Vély F, Narni-Mancinelli E, Vivier E.

Immunity. 2018 Nov 20;49(5):971-986.e5. doi: 10.1016/j.immuni.2018.09.009. Epub 2018 Nov 6.

3.

Neuroendocrine regulation of innate lymphoid cells.

Quatrini L, Vivier E, Ugolini S.

Immunol Rev. 2018 Nov;286(1):120-136. doi: 10.1111/imr.12707. Review.

4.

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.

Almeida FF, Tognarelli S, Marçais A, Kueh AJ, Friede ME, Liao Y, Willis SN, Luong K, Faure F, Mercier FE, Galluso J, Firth M, Narni-Mancinelli E, Rais B, Scadden DT, Spallotta F, Weil S, Giannattasio A, Kalensee F, Zöller T, Huntington ND, Schleicher U, Chiocchetti AG, Ugolini S, Herold MJ, Shi W, Koch J, Steinle A, Vivier E, Walzer T, Belz GT, Ullrich E.

Oncoimmunology. 2018 Aug 15;7(10):e1475875. doi: 10.1080/2162402X.2018.1475875. eCollection 2018.

5.

Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy.

Busti F, Marchi G, Ugolini S, Castagna A, Girelli D.

Pharmaceuticals (Basel). 2018 Sep 30;11(4). pii: E94. doi: 10.3390/ph11040094. Review.

6.

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells.

Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, Vivier E, Ugolini S.

Nat Immunol. 2018 Sep;19(9):954-962. doi: 10.1038/s41590-018-0185-0. Epub 2018 Aug 20.

7.

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).

Shovlin CL, Buscarini E, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Geisthoff U, Ugolini S, Dupuis-Girod S.

Orphanet J Rare Dis. 2018 Aug 15;13(1):136. doi: 10.1186/s13023-018-0850-2.

8.

[Neuroimmune interactions in the skin: a link between pain and immunity].

Debroas G, Hoeffel G, Reynders A, Ugolini S.

Med Sci (Paris). 2018 May;34(5):432-438. doi: 10.1051/medsci/20183405016. Epub 2018 Jun 13. Review. French.

9.

Robot-assisted thoracoscopic repair of a late-onset Bochdalek hernia: a case report.

Lima M, Di Salvo N, Ugolini S, Libri M, Ruggeri G.

Pediatr Med Chir. 2018 May 25;40(1). doi: 10.4081/pmc.2018.173.

10.

A unique case of foreign body aspiration and recurrent pneumothorax.

Lima M, Ugolini S, Di Salvo N, Libri M, Gargano T, Ruggeri G.

Pediatr Med Chir. 2017 Dec 15;39(4):171. doi: 10.4081/pmc.2017.171.

11.

Modern iron replacement therapy: clinical and pathophysiological insights.

Girelli D, Ugolini S, Busti F, Marchi G, Castagna A.

Int J Hematol. 2018 Jan;107(1):16-30. doi: 10.1007/s12185-017-2373-3. Epub 2017 Dec 1. Review.

PMID:
29196967
12.

Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells.

Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S.

J Exp Med. 2017 Dec 4;214(12):3531-3541. doi: 10.1084/jem.20171048. Epub 2017 Nov 15.

13.

Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.

Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A.

Circ Res. 2018 Jan 5;122(1):47-57. doi: 10.1161/CIRCRESAHA.117.311743. Epub 2017 Oct 18.

PMID:
29046274
14.

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E.

Sci Immunol. 2017 Apr 28;2(10). pii: eaam9628. doi: 10.1126/sciimmunol.aam9628.

15.

Regenerative Surgery in the Treatment of Cosmetic Defect Following Nuss Procedure.

Facchini F, Ghionzoli M, Martin A, Tanini S, Ugolini S, Lo Piccolo R, Messineo A.

J Laparoendosc Adv Surg Tech A. 2017 Jul;27(7):748-753. doi: 10.1089/lap.2016.0217. Epub 2017 Apr 26.

PMID:
28445085
16.

Disarming the Killers: Brain Strikes on NK Cells.

Quatrini L, Ugolini S.

Immunity. 2017 Mar 21;46(3):340-342. doi: 10.1016/j.immuni.2017.03.001.

17.

Left anterolateral emergency thoracotomy during the Nuss procedure: Lifesaving shortcut.

Ghionzoli M, Deaconu DE, Ugolini S, Lo Piccolo R, Messineo A.

Pediatr Int. 2017 Jan;59(1):103-104. doi: 10.1111/ped.13033. No abstract available.

PMID:
28102634
18.

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, Strasser A, Gray D, Hodgkin PD, Beutler B, Vivier E, Ugolini S, Huntington ND.

J Exp Med. 2017 Feb;214(2):491-510. doi: 10.1084/jem.20160869. Epub 2017 Jan 5.

19.

Manufacturing Natural Killer Cells as Medicinal Products.

Chabannon C, Mfarrej B, Guia S, Ugolini S, Devillier R, Blaise D, Vivier E, Calmels B.

Front Immunol. 2016 Nov 15;7:504. eCollection 2016. Review.

20.

A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory Arthritis.

Grossi V, Infantino M, Manfredi M, Meacci F, Bellio E, Bellio V, Gobbi FL, Ugolini S, Catani S, Sarzi-Puttini P, Atzeni F, Benucci M.

Curr Rheumatol Rev. 2017;13(2):93-97. doi: 10.2174/1573397112666160629085231.

PMID:
27363504
21.

SERUM CALPROTECTIN LEVELS AS A MARKER OF ARTHRITIS: AN ITALIAN EXPERIENCE.

Grossi V, Infantino M, Manfredi M, Meacci F, Bellio E, Bellio V, Gobbi FL, Ugolini S, Catani S, Sarzi-Puttini P, Atzeni F, Benucci M.

Curr Rheumatol Rev. 2016 Mar 31. [Epub ahead of print]

PMID:
27030256
22.

Complementarity and redundancy of IL-22-producing innate lymphoid cells.

Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld JC, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E.

Nat Immunol. 2016 Feb;17(2):179-86. doi: 10.1038/ni.3332. Epub 2015 Nov 30.

23.

Diagnostic accuracy of anti-gliadin antibodies in Non Celiac Gluten Sensitivity (NCGS) patients: A dual statistical approach.

Infantino M, Manfredi M, Meacci F, Grossi V, Severino M, Benucci M, Bellio E, Bellio V, Nucci A, Zolfanelli F, Ugolini S, Catani S, Macchia D.

Clin Chim Acta. 2015 Dec 7;451(Pt B):135-41. doi: 10.1016/j.cca.2015.09.017. Epub 2015 Sep 25.

PMID:
26404177
24.

The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study.

Scambi C, Ugolini S, Jokiranta TS, De Franceschi L, Bortolami O, La Verde V, Guarini P, Caramaschi P, Ravagnani V, Martignoni G, Colato C, Pedron S, Benedetti F, Sorio M, Poli F, Biasi D.

PLoS One. 2015 Feb 6;10(2):e0114856. doi: 10.1371/journal.pone.0114856. eCollection 2015.

25.

SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells.

Viant C, Fenis A, Chicanne G, Payrastre B, Ugolini S, Vivier E.

Nat Commun. 2014 Oct 30;5:5108. doi: 10.1038/ncomms6108.

PMID:
25355530
26.

Immunological memory within the innate immune system.

Sun JC, Ugolini S, Vivier E.

EMBO J. 2014 Jun 17;33(12):1295-303. doi: 10.1002/embj.201387651. Epub 2014 Mar 27. Review.

27.

Natural cytotoxicity receptors and their ligands.

Kruse PH, Matta J, Ugolini S, Vivier E.

Immunol Cell Biol. 2014 Mar;92(3):221-9. doi: 10.1038/icb.2013.98. Epub 2013 Dec 24. Review.

PMID:
24366519
28.

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

Kohrt HE, Thielens A, Marabelle A, Sagiv-Barfi I, Sola C, Chanuc F, Fuseri N, Bonnafous C, Czerwinski D, Rajapaksa A, Waller E, Ugolini S, Vivier E, Romagné F, Levy R, Bléry M, André P.

Blood. 2014 Jan 30;123(5):678-86. doi: 10.1182/blood-2013-08-519199. Epub 2013 Dec 10.

29.

ADAPted secretion of cytokines in NK cells.

Vivier E, Ugolini S, Nunès JA.

Nat Immunol. 2013 Nov;14(11):1108-10. doi: 10.1038/ni.2737. No abstract available.

PMID:
24145781
30.

T cell regulation of natural killer cells.

Kerdiles Y, Ugolini S, Vivier E.

J Exp Med. 2013 Jun 3;210(6):1065-8. doi: 10.1084/jem.20130960. Review.

31.

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.

Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, Farnarier C, Piperoglou C, Papazian L, Chaussabel D, Ugolini S, Vély F, Vivier E.

Blood. 2013 Jul 18;122(3):394-404. doi: 10.1182/blood-2013-01-481705. Epub 2013 May 17.

32.

[Natural killer cells: adaptation and memory in innate immunity].

Narni-Mancinelli E, Ugolini S, Vivier E.

Med Sci (Paris). 2013 Apr;29(4):389-95. doi: 10.1051/medsci/2013294012. Epub 2013 Apr 26. Review. French.

33.

Tuning the threshold of natural killer cell responses.

Narni-Mancinelli E, Ugolini S, Vivier E.

Curr Opin Immunol. 2013 Feb;25(1):53-8. doi: 10.1016/j.coi.2012.11.005. Epub 2012 Dec 25. Review.

PMID:
23270590
34.

Targeting natural killer cells and natural killer T cells in cancer.

Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L.

Nat Rev Immunol. 2012 Mar 22;12(4):239-52. doi: 10.1038/nri3174. Review.

35.

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis.

Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordoñez-Rueda D, Barlogis V, Mahlaoui N, Fenis A, Narni-Mancinelli E, Beaupain B, Bellanné-Chantelot C, Bajénoff M, Malissen B, Malissen M, Vivier E, Ugolini S.

J Exp Med. 2012 Mar 12;209(3):565-80. doi: 10.1084/jem.20111908. Epub 2012 Mar 5.

36.

Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.

Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, Mahmood S, Gut M, Heath SC, Estellé J, Bertosio E, Vely F, Gastinel LN, Beutler B, Malissen B, Malissen M, Gut IG, Vivier E, Ugolini S.

Science. 2012 Jan 20;335(6066):344-8. doi: 10.1126/science.1215621.

37.

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor.

Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18324-9. doi: 10.1073/pnas.1112064108. Epub 2011 Oct 21.

38.

Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance.

Guia S, Jaeger BN, Piatek S, Mailfert S, Trombik T, Fenis A, Chevrier N, Walzer T, Kerdiles YM, Marguet D, Vivier E, Ugolini S.

Sci Signal. 2011 Apr 5;4(167):ra21. doi: 10.1126/scisignal.2001608.

39.

Impact of β2 integrin deficiency on mouse natural killer cell development and function.

Crozat K, Eidenschenk C, Jaeger BN, Krebs P, Guia S, Beutler B, Vivier E, Ugolini S.

Blood. 2011 Mar 10;117(10):2874-82. doi: 10.1182/blood-2010-10-315457. Epub 2011 Jan 14.

40.

Innate or adaptive immunity? The example of natural killer cells.

Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S.

Science. 2011 Jan 7;331(6013):44-9. doi: 10.1126/science.1198687. Review.

41.

Natural killer cells: from basic research to treatments.

Vivier E, Ugolini S.

Front Immunol. 2011 Jun 3;2:18. doi: 10.3389/fimmu.2011.00018. eCollection 2011. No abstract available.

42.

Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response.

Vivier E, Ugolini S.

Cell Host Microbe. 2009 Dec 17;6(6):493-5. doi: 10.1016/j.chom.2009.12.001.

43.

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

Sola C, André P, Lemmers C, Fuseri N, Bonnafous C, Bléry M, Wagtmann NR, Romagné F, Vivier E, Ugolini S.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84. doi: 10.1073/pnas.0901653106. Epub 2009 Jun 26.

44.

Immunology: Natural killer cells remember.

Ugolini S, Vivier E.

Nature. 2009 Jan 29;457(7229):544-5. doi: 10.1038/457544a. No abstract available.

PMID:
19177118
45.

Functions of natural killer cells.

Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S.

Nat Immunol. 2008 May;9(5):503-10. doi: 10.1038/ni1582. Review.

PMID:
18425107
46.

TLR3 deficiency in patients with herpes simplex encephalitis.

Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL.

Science. 2007 Sep 14;317(5844):1522-7.

47.

Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.

Crozat K, Hoebe K, Ugolini S, Hong NA, Janssen E, Rutschmann S, Mudd S, Sovath S, Vivier E, Beutler B.

J Exp Med. 2007 Apr 16;204(4):853-63. Epub 2007 Apr 9. Erratum in: J Exp Med. 2008 Mar 17;205(3):737.

48.

Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells.

Baratin M, Roetynck S, Pouvelle B, Lemmers C, Viebig NK, Johansson S, Bierling P, Scherf A, Gysin J, Vivier E, Ugolini S.

PLoS One. 2007 Feb 21;2(2):e228.

49.

Natural killer cells and malaria.

Roetynck S, Baratin M, Johansson S, Lemmers C, Vivier E, Ugolini S.

Immunol Rev. 2006 Dec;214:251-63.

PMID:
17100890
50.

[NK cells and innate immunity to malaria].

Roetynck S, Baratin M, Vivier E, Ugolini S.

Med Sci (Paris). 2006 Aug-Sep;22(8-9):739-44. Review. French.

Supplemental Content

Loading ...
Support Center